Its "Country-of-origin labelling guidance" (Country of Origin Labeling Guidance 2008) suggests that in cases where manufacturers describe a product as "Produced in the UK", then the origin of any imported ingredients that characterise the product should be given.
Return to your Spiritual Self-Schema Blue-Print Worksheet and complete the section labeled Guidance and Support.
The Food and Drug Administration issues informal labeling guidance texts under § 10.90(b)(9) of this chapter to provide assistance in meeting the requirements of this section.
The Food and Drug Administration issues informal labeling guidance texts under § 10.90(b)(9) of this chapter to provide assistance in meeting the requirements of paragraph (c) of this section.
Additionally, these products may undermine the incentives to develop and submit new animal drug applications to FDA containing data and information to demonstrate that the product is safe, effective, properly manufactured, and accurately labeled (Guidance for Industry (Draft) (#230) 2015).
Various USDA labeling guidance documents offer inconsistent definitions for the free range claim.
W ij specifies the similarity or dissimilarity between examples x i and x j, which serves as the 'pairwise labeling' guidance for the embedding loss function.
In contrast, there is no label guidance on switching patients from PEG-Epo to DA, and to our knowledge only a single study, published only in abstract form, has examined outcomes associated with switching from PEG-Epo to DA [ 17].
In contrast, in the STRIATA study where stable hemodialysis patients receiving IV DA were randomized to Q2W PEG-Epo (outside current label guidance) or to continue on DA QW or Q2W, median PEG-Epo doses were described as stable across the 52-week post-switch period, although mean dose data were not reported [ 12].
There was considerable variation in the dose ratio of DA to PEG-Epo at the time of switching, which may have been driven by the lack of label guidance on dose conversion from PEG-Epo to DA, in the absence of which dose conversion likely reflected clinicians' preferences.
"FDA labeling guidance remains in place which requires labeling of material differences in foods, whether it be in composition, nutrition or safety".
